Výsledky vyhledávání - "T. M. Hommels"

Akademický článek

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS

Autor: T. M. Hommels, R. S. Hermanides, B. Berta, E. Fabris, G. De Luca, E. H. Ploumen, C. von Birgelen, E. Kedhi

Publikováno v: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)

Abstract Background Several studies compared everolimus-eluting bioresorbable scaffolds (EE-BRS) with everolimus-eluting stents (EES), but only few assessed these devices in patients with diabetes mellitus. Aim To evaluate the safety and efficacy out

Externí odkaz: https://doaj.org/article/15ac810077b443b492d1c4aa9d883688

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Autor: T. M. Hommels, R. S. Hermanides, S. Rasoul, B. Berta, A. J. J. IJsselmuiden, G. A. J. Jessurun, E. Benit, B. Pereira, G. De Luca, E. Kedhi

Publikováno v: Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-10 (2019)

Abstract Background Percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) remains challenging even with modern drug-eluting stents (DES) due to high rates of repeat revascularization. Everolimus-eluting bioresorbable scaffo

Externí odkaz: https://doaj.org/article/b6a1007823124237b68fd3352dbbb638

Zobrazit plný text záznamu

Plný text ve formátu HTML

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS

Autor: R. S. Hermanides, Eline H. Ploumen, Balázs Berta, Enrico Fabris, T. M. Hommels, Elvin Kedhi, G. De Luca, C. von Birgelen

Publikováno v: Cardiovascular diabetology, 19(1):165. BioMed Central
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Cardiovascular Diabetology

Background Several studies compared everolimus-eluting bioresorbable scaffolds (EE-BRS) with everolimus-eluting stents (EES), but only few assessed these devices in patients with diabetes mellitus. Aim To evaluate the safety and efficacy outcomes of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f248675102d58c9f297082582d0dbf8
http://hdl.handle.net/11368/2972783

Zobrazit plný text záznamu

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Autor: R. S. Hermanides, G. A. J. Jessurun, Alexander Ijsselmuiden, Balázs Berta, E. Kedhi, Bruno Pereira, T. M. Hommels, Edouard Benit, Saman Rasoul, G. De Luca

Publikováno v: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-10 (2019)

Background Percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) remains challenging even with modern drug-eluting stents (DES) due to high rates of repeat revascularization. Everolimus-eluting bioresorbable scaffolds (EE-B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e843e08c0576fc1a3a13f8759e56fe
http://hdl.handle.net/1942/31397

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání